Empagliflozin/metformin Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in diabetes | Endocrine System
Items (12m)
56
Total Quantity
3,140
NHS Cost
£1.9K
vs National Avg
+7.6%
MAPLE ACCESS PARTNERSHIP LLP prescribed 56 items of Empagliflozin/metformin over the last 12 months at a cost of £1,950 to the NHS. This is 7.6% above the national average prescribing rate. Empagliflozin/metformin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
5
Jun 2026
3
Jun 2026
3
Jun 2026
5
Jun 2026
3
Jun 2026
8
Jun 2026
4
Jun 2026
6
Jun 2026
4
Jun 2026
5
Jun 2026
5
Jun 2026
5
Prescribing Details
| Total Items | 56 |
|---|---|
| Total Quantity | 3,140 |
| Total NHS Cost | £1,950 |
| Presentations | 2 different forms |
| vs National Average | +7.6% |
Empagliflozin/metformin Prescribing Comparison
| This practice | 56 items |
|---|---|
| National average per practice | 52 items |
| Difference | +7.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.